Severe Hypertrophic Cardiomyopathy in an Infant with a Novel PRKAG2 Gene Mutation: Potential Differences Between Infantile and Adult Onset Presentation |
| |
Authors: | Brendan P. Kelly Mark W. Russell James R. Hennessy Gregory J. Ensing |
| |
Affiliation: | (1) Division of Pediatric Cardiology, University of Michigan, Ann Arbor, USA;(2) Toledo, OH, USA |
| |
Abstract: | Hypertrophic cardiomyopathy (HCM) is a heterogeneous disorder characterized by thickening of the heart and an increased incidence of sudden death. This study is aimed to determine the genetic cause of severe cardiac hypertrophy in an infant. An infant was assigned a diagnosis of ventricular preexcitation and severe biventricular HCM requiring septal myectomy. Genetic testing showed a novel heterozygous E506Q mutation of the adenosine monophosphate (AMP)-activated protein kinase (PRKAG2) gene. Endomyocardial biopsy samples did not demonstrate significant glycogen accumulation. Hypertrophic cardiomyopathy due to PRKAG2 mutations may have a degree of cardiac hypertrophy exceeding that expected from observed amounts of glycogen deposition. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |